Reuters logo
BRIEF-Integra Lifesciences to sell neurosurgery assets to Natus Medical
September 11, 2017 / 11:40 AM / 2 months ago

BRIEF-Integra Lifesciences to sell neurosurgery assets to Natus Medical

Sept 11 (Reuters) - Integra Lifesciences Holdings Corp

* Integra Lifesciences announces definitive agreement to sell certain neurosurgery assets to Natus Medical Incorporated

* Integra Lifesciences announces definitive agreement to sell certain neurosurgery assets to Natus Medical Incorporated

* Integra Lifesciences - preliminary estimate for Q4 2017 revenue contribution of about $60 million-$65 million from acquisition of Codman Neurosurgery, net of divestitures​

* Integra Lifesciences- continues to expect Codman Neurosurgery’s accretive contribution to adjusted earnings per share to be at least $0.22 in 2018

* Integra Lifesciences - ‍for FY 2018, Integra expects Codman Neurosurgery to contribute between $290 million and $300 million in revenue, net of divestitures​

* Integra Lifesciences - ‍continues to Expect Codman Neurosurgery’s accretive contribution to adjusted earnings per share to be at least $0.22 in 2018​

* Integra Lifesciences Holdings - ‍divestiture contingent on consummation of Integra’s proposed acquisition of Codman Neurosurgery from Johnson & Johnson​

* Integra Lifesciences Holdings Corp - ‍for full year 2017, integra expects minimal contribution from Codman Neurosurgery to adjusted earnings per share​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below